Amgen Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was USD 6,238 million compared to USD 5,901 million a year ago. Net income was USD 1,476 million compared to USD 1,646 million a year ago. Basic earnings per share from continuing operations was USD 2.69 compared to USD 2.85 a year ago. Diluted earnings per share from continuing operations was USD 2.68 compared to USD 2.83 a year ago.